Literature DB >> 576414

Ophthalmic Graves's disease: natural history and detailed thyroid function studies.

C S Teng, P P Yeo.   

Abstract

Of 27 patients with ophthalmic Graves's disease (OGD) who had been clinically euthyroid three years previously, one became clinically hyperthyroid and seven overtly hypothyroid. Improvement in eye signs was associated with a return to normal of thyroidal suppression by triiodothyronine (T3) and of the response of thyroid-stimulating hormone (TSH) to thyrotrophin-releasing hormone (TRH). Of a further 30 patients with OGD who had not been studied previously, three were overtly hypothyroid. Of the combined series, 46 patients were euthyroid, 18 (40%) of whom had an impaired or absent TSH response to TRH, and 3(6-7%) an exaggerated response. Eleven out of 37 patients (29-7%) had abnormal results in the T3 suppression test. There was a significant correlation between thyroidal suppression by T3 and the TSH response to TRH. Total serum concentrations of both T3 and thyroxine (T4) were closely correlated with T3 suppressibility and TRH responsiveness. Free T4 and T3 (fT3) concentrations were normal in all but three patients, in whom raised fT3 was accompanied by abnormal TSH responses and thyroidal suppression. The presence of normal free thyroid hormone concentrations in patients with impaired or absent TSH responses to TRH is interesting and challenges the concept that free thyroid hormones are the major controlling factors in the feedback control of TSH.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 576414      PMCID: PMC1604143          DOI: 10.1136/bmj.1.6056.273

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  Thyrotrophin response to thyrotrophin-releasing hormone in ophthalmic Graves' disease: correlation with other aspects of thyroid function, thyroid suppressibility and activity of eye signs.

Authors:  B J Ormston; L Alexander; D C Evered; F Clark; T Bird; D Appleton; R Hall
Journal:  Clin Endocrinol (Oxf)       Date:  1973-10       Impact factor: 3.478

2.  The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus.

Authors:  R Hall; B J Ormston; G M Besser; R J Cryer
Journal:  Lancet       Date:  1972-04-08       Impact factor: 79.321

3.  Thyrotrophin-releasing hormone as a thyroid-function test.

Authors:  B J Ormston; R J Cryer; R Garry; G M Besser; R Hall
Journal:  Lancet       Date:  1971-07-03       Impact factor: 79.321

4.  Supervoltage orbital radiotherapy for Graves' ophthalmopathy.

Authors:  S S Donaldson; M A Bagshaw; J P Kriss
Journal:  J Clin Endocrinol Metab       Date:  1973-08       Impact factor: 5.958

5.  Ophthalmic Graves' disease. Diagnosis and pathogenesis.

Authors:  R Hall; K Kirkham; D Doniach; D el-Kabir
Journal:  Lancet       Date:  1970-02-21       Impact factor: 79.321

6.  Radioimmunoassay of triiodothyronine in unextracted human serum.

Authors:  R D Hesch; D Evered
Journal:  Br Med J       Date:  1973-03-17

7.  Classification of the eye changes of Grave's disease.

Authors:  S C Werner
Journal:  J Clin Endocrinol Metab       Date:  1969-07       Impact factor: 5.958

8.  Graves' disease without hyperthyroidism.

Authors:  G W Liddle; R M Heyssel; J M McKenzie
Journal:  Am J Med       Date:  1965-11       Impact factor: 4.965

  8 in total
  11 in total

Review 1.  Autoimmunity in Graves' ophthalmopathy: a review.

Authors:  A P Weetman
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

2.  Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisited.

Authors:  Francesca Menconi; Maria Antonietta Profilo; Marenza Leo; Eleonora Sisti; Maria Antonietta Altea; Roberto Rocchi; Francesco Latrofa; Marco Nardi; Paolo Vitti; Claudio Marcocci; Michele Marinò
Journal:  Thyroid       Date:  2013-12-09       Impact factor: 6.568

3.  CT features of exophthalmos in Chinese subjects with thyroid-associated ophthalmopathy.

Authors:  Zhi-Jia Fang; Jenny Y Zhang; Wei-Min He
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

Review 4.  Natural course of mild Graves' orbitopathy: is it a chronic remitting or a transient disease?

Authors:  P Anagnostis; K Boboridis; F Adamidou; M Kita
Journal:  J Endocrinol Invest       Date:  2016-09-23       Impact factor: 4.256

5.  Long-term follow-up of ophthalmic Graves' disease.

Authors:  P J Agapitos; I R Hart
Journal:  CMAJ       Date:  1987-02-15       Impact factor: 8.262

6.  Progress in endocrine exophthalmos.

Authors:  C W Havard
Journal:  Br Med J       Date:  1979-04-14

Review 7.  Ocular manifestations of Graves' disease: a review.

Authors:  A P Weetman; A M McGregor; R Hall
Journal:  J R Soc Med       Date:  1984-11       Impact factor: 5.344

8.  Dysthyroid ophthalmopathy: an update.

Authors:  L A Young
Journal:  J Natl Med Assoc       Date:  1979-09       Impact factor: 1.798

9.  Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question.

Authors:  Elena Sabini; Marenza Leo; Barbara Mazzi; Roberto Rocchi; Francesco Latrofa; Marco Nardi; Paolo Vitti; Claudio Marcocci; Michele Marinò
Journal:  Eur Thyroid J       Date:  2017-06-26

10.  The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Authors:  G B Bartley
Journal:  Trans Am Ophthalmol Soc       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.